Related Experiment Video
Updated: Jun 17, 2025

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Data sharing in cancer research: A qualitative study exploring community members' preferences
Elizabeth A Johnston1,2,3, Xanthia E Bourdaniotis1, Susannah K Ayre1,2
1Cancer Council Queensland, Fortitude Valley, Queensland, Australia.
Cancer survivors and carers are willing to share health data for research. Key factors influencing consent include potential benefits, researcher transparency, data control, and privacy protections.
Area of Science:
- Oncology
- Health Informatics
- Patient Advocacy
Background:
- Cancer survivorship and treatment advancements depend on research participation and health record access.
- Community engagement is crucial for understanding patient perspectives on data sharing.
Purpose of the Study:
- To explore cancer survivors' and carers' preferences regarding health data access and sharing for research.
- To identify factors influencing willingness to consent to data sharing in cancer research.
Main Methods:
- Conducted 14 workshops with 42 community members, primarily cancer survivors or carers.
- Presented various data access and sharing scenarios for discussion.
- Analyzed participant preferences using descriptive and thematic analysis.
Main Results:
- 86% of participants were willing to share self-report data and current health records for specific research.
- 62% and 44% were willing to share current and future health records, respectively, with other researchers.
- Willingness was influenced by potential medical advancements, researcher transparency, data control, and privacy protocols.
Conclusions:
- Developed practical strategies to optimize data access and sharing in cancer research based on community preferences.
- Emphasized the importance of transparency, control, and privacy in facilitating data sharing for cancer research.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancers Originate from Somatic Mutations in a Single Cell

